High-yield soluble expression of recombinant influenza virus antigens from Escherichia coli and their potential uses in diagnosis

Yo Han Jang, Seung Hee Cho, Ahyun Son, Yun Ha Lee, Jinhee Lee, Kwang Hee Lee, Baik Lin Seong

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Although antiviral drugs and vaccines have been successful for mitigating influenza virus infections, the lack of general technical platform for the timely supply of soluble and highly purified influenza viral antigens presents a serious bottleneck for the subsequent analysis for the effective control of the viral disease. Using the Escherichia coli (E. coli) lysyl tRNA synthetase (LysRS) as a novel fusion partner, this study reports the soluble expression of influenza viral proteins in E. coli host, construction of antibody library against the virus, and detection of anti-influenza antibodies using the expressed viral antigens. When influenza A and B viral proteins were fused with the LysRS, the fusion proteins were expressed predominantly as soluble forms and their production yields were high enough to be amenable to immunization protocols in rabbits for antibody generation. The produced antibodies showed high level binding specificity against the respective viral proteins, with cross-reactivity across heterologous viruses within the same type of influenza viruses. In addition, LysRS-HA fusion protein could bind specifically to anti-HA antibodies in the virus-infected mouse serum in widely accepted two detection methods, Western blot and ELISA. These results present a convenient tool for the production of antibodies specific to the virus as well as the rapid detection of influenza viral infections, ultimately contributing to the control of influenza viruses including highly pathogenic H5N1, pandemic H1N1, or the recent H7N9 influenza viruses.

Original languageEnglish
Pages (from-to)56-64
Number of pages9
JournalJournal of Virological Methods
Volume196
DOIs
Publication statusPublished - 2014 Feb 1

Fingerprint

Orthomyxoviridae
Lysine-tRNA Ligase
Human Influenza
Escherichia coli
Antigens
Viral Proteins
Virus Diseases
Viruses
Viral Antigens
Antibodies
Anti-Idiotypic Antibodies
H7N9 Subtype Influenza A Virus
Pandemics
Antibody Formation
Antiviral Agents
Immunization
Proteins
Vaccines
Western Blotting
Enzyme-Linked Immunosorbent Assay

All Science Journal Classification (ASJC) codes

  • Virology

Cite this

Jang, Yo Han ; Cho, Seung Hee ; Son, Ahyun ; Lee, Yun Ha ; Lee, Jinhee ; Lee, Kwang Hee ; Seong, Baik Lin. / High-yield soluble expression of recombinant influenza virus antigens from Escherichia coli and their potential uses in diagnosis. In: Journal of Virological Methods. 2014 ; Vol. 196. pp. 56-64.
@article{f1d714d2ce964eed9d5aa9c7260560dc,
title = "High-yield soluble expression of recombinant influenza virus antigens from Escherichia coli and their potential uses in diagnosis",
abstract = "Although antiviral drugs and vaccines have been successful for mitigating influenza virus infections, the lack of general technical platform for the timely supply of soluble and highly purified influenza viral antigens presents a serious bottleneck for the subsequent analysis for the effective control of the viral disease. Using the Escherichia coli (E. coli) lysyl tRNA synthetase (LysRS) as a novel fusion partner, this study reports the soluble expression of influenza viral proteins in E. coli host, construction of antibody library against the virus, and detection of anti-influenza antibodies using the expressed viral antigens. When influenza A and B viral proteins were fused with the LysRS, the fusion proteins were expressed predominantly as soluble forms and their production yields were high enough to be amenable to immunization protocols in rabbits for antibody generation. The produced antibodies showed high level binding specificity against the respective viral proteins, with cross-reactivity across heterologous viruses within the same type of influenza viruses. In addition, LysRS-HA fusion protein could bind specifically to anti-HA antibodies in the virus-infected mouse serum in widely accepted two detection methods, Western blot and ELISA. These results present a convenient tool for the production of antibodies specific to the virus as well as the rapid detection of influenza viral infections, ultimately contributing to the control of influenza viruses including highly pathogenic H5N1, pandemic H1N1, or the recent H7N9 influenza viruses.",
author = "Jang, {Yo Han} and Cho, {Seung Hee} and Ahyun Son and Lee, {Yun Ha} and Jinhee Lee and Lee, {Kwang Hee} and Seong, {Baik Lin}",
year = "2014",
month = "2",
day = "1",
doi = "10.1016/j.jviromet.2013.10.035",
language = "English",
volume = "196",
pages = "56--64",
journal = "Journal of Virological Methods",
issn = "0166-0934",
publisher = "Elsevier",

}

High-yield soluble expression of recombinant influenza virus antigens from Escherichia coli and their potential uses in diagnosis. / Jang, Yo Han; Cho, Seung Hee; Son, Ahyun; Lee, Yun Ha; Lee, Jinhee; Lee, Kwang Hee; Seong, Baik Lin.

In: Journal of Virological Methods, Vol. 196, 01.02.2014, p. 56-64.

Research output: Contribution to journalArticle

TY - JOUR

T1 - High-yield soluble expression of recombinant influenza virus antigens from Escherichia coli and their potential uses in diagnosis

AU - Jang, Yo Han

AU - Cho, Seung Hee

AU - Son, Ahyun

AU - Lee, Yun Ha

AU - Lee, Jinhee

AU - Lee, Kwang Hee

AU - Seong, Baik Lin

PY - 2014/2/1

Y1 - 2014/2/1

N2 - Although antiviral drugs and vaccines have been successful for mitigating influenza virus infections, the lack of general technical platform for the timely supply of soluble and highly purified influenza viral antigens presents a serious bottleneck for the subsequent analysis for the effective control of the viral disease. Using the Escherichia coli (E. coli) lysyl tRNA synthetase (LysRS) as a novel fusion partner, this study reports the soluble expression of influenza viral proteins in E. coli host, construction of antibody library against the virus, and detection of anti-influenza antibodies using the expressed viral antigens. When influenza A and B viral proteins were fused with the LysRS, the fusion proteins were expressed predominantly as soluble forms and their production yields were high enough to be amenable to immunization protocols in rabbits for antibody generation. The produced antibodies showed high level binding specificity against the respective viral proteins, with cross-reactivity across heterologous viruses within the same type of influenza viruses. In addition, LysRS-HA fusion protein could bind specifically to anti-HA antibodies in the virus-infected mouse serum in widely accepted two detection methods, Western blot and ELISA. These results present a convenient tool for the production of antibodies specific to the virus as well as the rapid detection of influenza viral infections, ultimately contributing to the control of influenza viruses including highly pathogenic H5N1, pandemic H1N1, or the recent H7N9 influenza viruses.

AB - Although antiviral drugs and vaccines have been successful for mitigating influenza virus infections, the lack of general technical platform for the timely supply of soluble and highly purified influenza viral antigens presents a serious bottleneck for the subsequent analysis for the effective control of the viral disease. Using the Escherichia coli (E. coli) lysyl tRNA synthetase (LysRS) as a novel fusion partner, this study reports the soluble expression of influenza viral proteins in E. coli host, construction of antibody library against the virus, and detection of anti-influenza antibodies using the expressed viral antigens. When influenza A and B viral proteins were fused with the LysRS, the fusion proteins were expressed predominantly as soluble forms and their production yields were high enough to be amenable to immunization protocols in rabbits for antibody generation. The produced antibodies showed high level binding specificity against the respective viral proteins, with cross-reactivity across heterologous viruses within the same type of influenza viruses. In addition, LysRS-HA fusion protein could bind specifically to anti-HA antibodies in the virus-infected mouse serum in widely accepted two detection methods, Western blot and ELISA. These results present a convenient tool for the production of antibodies specific to the virus as well as the rapid detection of influenza viral infections, ultimately contributing to the control of influenza viruses including highly pathogenic H5N1, pandemic H1N1, or the recent H7N9 influenza viruses.

UR - http://www.scopus.com/inward/record.url?scp=84888123350&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84888123350&partnerID=8YFLogxK

U2 - 10.1016/j.jviromet.2013.10.035

DO - 10.1016/j.jviromet.2013.10.035

M3 - Article

C2 - 24216235

AN - SCOPUS:84888123350

VL - 196

SP - 56

EP - 64

JO - Journal of Virological Methods

JF - Journal of Virological Methods

SN - 0166-0934

ER -